Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-22-042256
Filing Date
2022-02-14
Accepted
2022-02-14 17:24:21
Documents
3
Group Members
BESSEMER VENTURE PARTNERS IX INSTITUTIONAL L.P.BESSEMER VENTURE PARTNERS IX L.P.DEER IX & CO. L.P.

Document Format Files

Seq Description Document Type Size
1 SC 13G d310747dsc13g.htm SC 13G 93189
2 EXHIBIT 1 d310747dex991.htm EX-99.1 6216
3 EXHIBIT 2 d310747dex992.htm EX-99.2 1046
  Complete submission text file 0001193125-22-042256.txt   102137
Mailing Address C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVENUE, SUITE 104 LARCHMONT NY 10538
Business Address C/O BESSEMER VENTURE PARTNERS 1865 PALMER AVENUE, SUITE 104 LARCHMONT NY 10538 914-833-5300
Deer IX & Co. Ltd. (Filed by) CIK: 0001655220 (see all company filings)

EIN.: 981208903 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 830 WINTER STREET WALTHAM MA 02451
Business Address 830 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Subject) CIK: 0001783328 (see all company filings)

EIN.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92700 | Film No.: 22635079
SIC: 2836 Biological Products, (No Diagnostic Substances)